Kintara Therapeutics Inc (NASDAQ:KTRA) shares, rose in value, with the stock price up by 63.35% to the previous day’s close as strong demand from buyers drove the stock to $0.16.
Actively observing the price movement in the last trading, the stock closed the session at $0.10. The value of beta (5-year monthly) was 0.59. Referring to stock’s 52-week performance, its high was $5.98, and the low was $0.08. On the whole, KTRA has fluctuated by 72.45% over the past month.
With the market capitalization of Kintara Therapeutics Inc currently standing at about $6.40 million, investors are eagerly awaiting this quarter’s results, scheduled for May 09, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0, which is expected to increase to $0 for fiscal year -$0.46 and then to about -$0.38 by fiscal year 2025. Data indicates that the EPS growth is expected to be 95.00% in 2025, while the next year’s EPS growth is forecast to be 17.40%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that KTRA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of KTRA currently trading nearly 73.43% and 54.56% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 72.67, while the 7-day volatility ratio is showing 19.67% which for the 30-day chart, stands at 12.33%. Furthermore, Kintara Therapeutics Inc (KTRA)’s beta value is 0.59, and its average true range (ATR) is 0.02.
A comparison of Kintara Therapeutics Inc (KTRA) with its peers suggests the former has fared considerably weaker in the market. KTRA showed an intraday change of 63.35% in last session, and over the past year, it shrunk by -95.35%%.
Data on historical trading for Kintara Therapeutics Inc (NASDAQ:KTRA) indicates that the trading volumes over the past 10 days have averaged 30.78 million and over the past 3 months, they’ve averaged 11.58 million. According to company’s latest data on outstanding shares, there are 39.04 million shares outstanding.
Nearly 0.19% of Kintara Therapeutics Inc’s shares belong to company insiders and institutional investors own 0.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.2 million shares as on Mar 15, 2024, resulting in a short ratio of 0.11. According to the data, the short interest in Kintara Therapeutics Inc (KTRA) stood at 5.63% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.41 million. The stock has fallen by -3.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the KTRA stock heading into the next quarter.
